Biocodex

Biocodex is an independent, family-owned French pharmaceutical company founded in 1953. Biocodex has transformed itself beyond its probiotic drug roots, expanding its portfolio into numerous therapeutic areas which include: Gastroenterology, Pain management, Neurology/Psychiatry, Otolaryngology, and Rheumatology.

Biocodex S.A., a pharmaceutical company, researches, develops, manufactures, and commercializes pharmaceutical products for various therapeutic areas. It offers products in the areas of gastroenterology, pain management, neurology/psychiatry, otolaryngology, and rheumatology. The company sells its products through a network of wholly owned subsidiaries, licensees, distributors, and licensed retailers worldwide. Biocodex S.A. was founded in 1953 and is based in Gentilly, France. It has subsidiaries in Belgium, Morocco, the Russian Federation, Ukraine, Turkey, the United States, Mexico, and Canada.

Biocodex, Inc., a pharmaceutical company, manufactures probiotic supplements using live freeze dried yeast cells of the species Saccharomyces boulardii. The company offers Florastor, a probiotic capsule for adults, which aids in the growth of good microorganisms, and helps maintain the balance in intestines and normal bowel function. It also provides Florastor in powder formulation for infants and children. The company was incorporated in 1987 and is based in Redwood City, California. Biocodex, Inc. operates as a subsidiary of Biocodex S.A.

Biocodex has invested in Nextbiotix on Jul 6, 2018. This investment, -Series A- Nextbiotix - was valued at €7M.